Prescribing Advisory Sub Group

The Prescribing Advisory Subgroup is a subgroup of the RCAG. The purpose of the group is:

• to facilitate a consistent and effective approach to the managed entry of cancer medicines across the West of Scotland.
• to promote and monitor the equitable provision of safe, clinical and cost effective cancer medicines.

• To promote consistency in the application of and equitable patient access to current evidence-based best practice and existing oncology medicines.
• To provide advice to Health Boards and Area Drug and Therapeutics Committees (ADTC) on the managed entry of new cancer medicines including:
  • the impact of any proposed changes to prescribing practice as a consequence of new or modified MCN guidelines.
  • the impact and application of cancer medicines subject to SMC and other national guidance in the West of Scotland.
  • the appropriate use of unlicensed and exceptional use of non approved cancer medicines.
• To promote the optimal use of cancer medicines, including location of treatment, across the West of Scotland.
• To monitor implementation of guidelines and patterns of medicine usage and  identify areas appropriate for audit of clinical effectiveness.
• To support regional and local advance planning for the introduction of new cancer medicines in collaboration with Scottish Medicines Consortium Horizon Scanning Division.